Metrology and visualization analysis of literatures related to tumor immunotherapy based on CiteSpace

IF 0.4 Q4 MEDICINE, RESEARCH & EXPERIMENTAL Precision Medical Sciences Pub Date : 2023-03-28 DOI:10.1002/prm2.12099
Weidong Ma, Zhi-yun Xu, Qianwei Wang, Zhenzhong Zhang, Derong Tang, Jianqiang Zhao
{"title":"Metrology and visualization analysis of literatures related to tumor immunotherapy based on CiteSpace","authors":"Weidong Ma, Zhi-yun Xu, Qianwei Wang, Zhenzhong Zhang, Derong Tang, Jianqiang Zhao","doi":"10.1002/prm2.12099","DOIUrl":null,"url":null,"abstract":"To explore the development of global tumor immunotherapy in the past 20 years, and analyze the research status, hotspots and trends to provide theoretical support for subsequent research. CiteSpace 5.6.R2 software were used to analyze 290 articles related to tumor immunotherapy research from the Web of Science core data set from 2000 to 2019. CiteSpace was used to draw related visual maps and tables of coauthors, cooperating countries, cooperating institutions, literature and journal co‐citation, keyword co‐occurrence, and cluster analysis. The total amount of papers published in the field of tumor immunotherapy research has gradually increased. After receiving the Nobel Prize in Physiology or Medicine in 2018, the number of papers published in the field of research in tumor research reached 20. We found that the United States has the largest number of papers in all countries and China ranks 6. “Proceedings of the National Academy of Sciences of the United States of America,” “Journal of Immunology,” “Cancer Research,” “New England Journal of Medicine,” “Blood” is the top five core academic journals in this field. Cancer, disease, and tumor necrosis factor are the three keywords with the highest highlighting intensity. Comprehensive analysis shows that the coauthors, co‐institutions, and co‐cited journals of the literature are mostly concentrated in the United States. The rise of immunotherapy provides a new direction for tumor treatment. From 2018 to 2019, the number of literatures on tumor immunotherapy worldwide increased sharply. Immunotherapy combined with specific diseases is the current research frontier and hotspot.","PeriodicalId":40071,"journal":{"name":"Precision Medical Sciences","volume":"12 1","pages":"159 - 169"},"PeriodicalIF":0.4000,"publicationDate":"2023-03-28","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Precision Medical Sciences","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1002/prm2.12099","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q4","JCRName":"MEDICINE, RESEARCH & EXPERIMENTAL","Score":null,"Total":0}
引用次数: 0

Abstract

To explore the development of global tumor immunotherapy in the past 20 years, and analyze the research status, hotspots and trends to provide theoretical support for subsequent research. CiteSpace 5.6.R2 software were used to analyze 290 articles related to tumor immunotherapy research from the Web of Science core data set from 2000 to 2019. CiteSpace was used to draw related visual maps and tables of coauthors, cooperating countries, cooperating institutions, literature and journal co‐citation, keyword co‐occurrence, and cluster analysis. The total amount of papers published in the field of tumor immunotherapy research has gradually increased. After receiving the Nobel Prize in Physiology or Medicine in 2018, the number of papers published in the field of research in tumor research reached 20. We found that the United States has the largest number of papers in all countries and China ranks 6. “Proceedings of the National Academy of Sciences of the United States of America,” “Journal of Immunology,” “Cancer Research,” “New England Journal of Medicine,” “Blood” is the top five core academic journals in this field. Cancer, disease, and tumor necrosis factor are the three keywords with the highest highlighting intensity. Comprehensive analysis shows that the coauthors, co‐institutions, and co‐cited journals of the literature are mostly concentrated in the United States. The rise of immunotherapy provides a new direction for tumor treatment. From 2018 to 2019, the number of literatures on tumor immunotherapy worldwide increased sharply. Immunotherapy combined with specific diseases is the current research frontier and hotspot.
查看原文
分享 分享
微信好友 朋友圈 QQ好友 复制链接
本刊更多论文
基于CiteSpace的肿瘤免疫治疗相关文献计量与可视化分析
探索过去20年全球肿瘤免疫疗法的发展 并分析研究现状、热点和趋势,为后续研究提供理论支持。CiteSpace 5.6.R2软件用于分析2000年至2019年科学网核心数据集中290篇与肿瘤免疫治疗研究相关的文章。CiteSpace用于绘制合著者、合作国家、合作机构、文献和期刊共引、关键词共现和聚类分析的相关视觉地图和表格。肿瘤免疫治疗研究领域的论文发表总量逐渐增加。2018年获得诺贝尔生理学或医学奖后,在肿瘤研究领域发表的论文数量达到20篇。我们发现,美国的论文数量是所有国家中最多的,中国排名第6。《美国国家科学院院刊》、《免疫学杂志》、《癌症研究》、《新英格兰医学杂志》和《血液》是该领域的五大核心学术期刊。癌症、疾病和肿瘤坏死因子是突出强度最高的三个关键词。综合分析表明,该文献的合著者、合作机构和被引用期刊大多集中在美国。免疫疗法的兴起为肿瘤治疗提供了新的方向。从2018年到2019年,全球范围内关于肿瘤免疫治疗的文献数量急剧增加。免疫治疗结合特定疾病是目前研究的前沿和热点。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 去求助
来源期刊
Precision Medical Sciences
Precision Medical Sciences MEDICINE, RESEARCH & EXPERIMENTAL-
自引率
0.00%
发文量
33
审稿时长
15 weeks
期刊最新文献
Prostatectomy postoperative urinary incontinence: From origin to treatment A case report of adult type 2 familial hemophagocytic lymphohistiocytosis Which inflammatory marker might be the best indicator for sacroiliitis? miRNAs involvement in the etiology and targeted therapy of bladder cancer: Interaction between signaling pathway Xiaotan Sanjie Fang prevents colonic inflammation‐related tumorigenesis by inhibiting COX‐2/VEGF expression cancer
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
现在去查看 取消
×
提示
确定
0
微信
客服QQ
Book学术公众号 扫码关注我们
反馈
×
意见反馈
请填写您的意见或建议
请填写您的手机或邮箱
已复制链接
已复制链接
快去分享给好友吧!
我知道了
×
扫码分享
扫码分享
Book学术官方微信
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术
文献互助 智能选刊 最新文献 互助须知 联系我们:info@booksci.cn
Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。
Copyright © 2023 Book学术 All rights reserved.
ghs 京公网安备 11010802042870号 京ICP备2023020795号-1